Ocular Surface Disease Now Included

ROCHESTER, New York, USA, May 6, 2024 – Acuity Polymers, a leader in polymer science innovation for the development of specialty contact lens materials, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded indications of its Acuity 200™ (fluoroxyfocon A) and Acuity 100™ (hexafocon A) daily wear gas permeable contact lenses, [510(k) Number K240618]. The newly granted FDA clearance includes the option of treating the contact lenses with Tangible® Hydra- PEG®.

ROCHESTER, N.Y., January 13, 2022-- Acuity Polymers, a leading developer of specialty contact lens materials announced it has received the US Food and Drug Administration’s 510(k) clearance for use of the Tangible® Hydra-PEG® custom contact lens coating technology with its Ultra Dk Acuity 200 gas permeable (GP) material.

Designed to address contact lens discomfort and dryness, Tangible® Hydra-PEG® is a high-water polymer coating that is bonded to the surface of a contact lens. With this coating technology, eye care professionals can enhance contact lens customization for their patients using the industry’s highest Dk Acuity 200 material.

Rochester, N.Y. April 28, 2020, Acuity Polymers, an eyecare company specializing in the development of innovative specialty contact lens materials, announced today that the U.S. Patent and Trademark Office (“USPTO”) issued U.S. Pat. No. 10,633,472 relating to an ultra-high gas permeable (GP) material for use in contact lenses. Acuity Polymers’ patent is issued for a method utilizing specialized temperature-pressure conditions sufficient to provide an ultra-high permeability material.

ROCHESTER, N.Y. (USA), April 14, 2021 

Acuity Polymers, a leading developer of innovative contact lens materials, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for expanded indications of its ACUITY 200™ Ultra Dk daily wear gas permeable contact lenses [510(k) Number K203571].

ACUITY 200 contact lenses may now be prescribed for daily wear in otherwise non-diseased eyes that require a rigid contact lens for the management of irregular corneal conditions such as keratoconus, pellucid marginal degeneration, or following penetrating keratoplasty or refractive (e.g., LASIK) surgery.

Rochester, NY (USA), December 3, 2018 – Acuity Polymers, Inc. announced today that it has acquired the full range of Lagado contact lens materials from Menicon America.
Lagado Corporation will cease operations and the manufacture of the Lagado materials will be moved to Acuity Polymers in Rochester, NY. The acquisition of Lagado’s GP and soft contact lens materials by Acuity Polymers will enable Acuity Polymers to broaden its product range and customer base. This will help Acuity Polymers expand its global presence in the custom contact lens materials market.

Rochester, NY (USA). (September 8, 2020) – Acuity Polymers, a leading developer of contact lens materials, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ACUITY 200™ daily wear gas permeable contact lenses, in a variety of designs and indications.

Rochester, NY (USA). (June 2, 2017) – Acuity Polymers, Inc. is proud to announce US FDA clearance of the Acuity 58 (enflufocon B) Gas Permeable (GP) contact lens and the Acuity 85 (oprifocon A) Gas Permeable contact lens. Acuity 58 and Acuity 85 GP Lenses will be available soon from custom contact lens laboratories in the US and across the world.

  1. Acuity Polymers, Inc. receives FDA Clearance for Acuity 18
  2. Acuity Polymers, Inc. Receives FDA Clearance for Acuity 100
  3. Acuity Polymers, Inc. Receives ISO Certifications